Safety of Human Immunisation With a Live-attenuated Mycobacterium Tuberculosis Vaccine: a Randomised, Double-blind, Controlled Phase I Trial

Spertini et al., The Lancet Respiratory Medicine (2015) - PMID: n.a

Product(s) used in this publication: PepMix™ Peptide Pools

Sorry, currently there is no abstract available.

Stay in touch and be the first to receive the latest news!